
Hims & Hers Health (HIMS) is presented as a significantly undervalued growth company, with its newly acquired painless micro-needle technology acting as a major long-term catalyst. The investment thesis for Tesla (TSLA) is expanding beyond EVs, as Wall Street has not yet priced in the massive potential of its Optimus robotics project. For high-risk, high-reward exposure to Web3, consider Solana (SOL), a blockchain protocol positioned to take market share from Ethereum. A potential value play is DeFi Technologies (DEFI.NE), which offers discounted exposure as it has been trading for less than the value of its SOL holdings. For a lower-volatility yield opportunity, MicroStrategy's "Stretch" instrument is expected to return to its $100 price target following a recent yield increase.

By @BeatTheDenominator